Based on the HEALIOS K.K. stock forecast from 0 analysts, the average analyst target price for HEALIOS K.K. is not available over the next 12 months. HEALIOS K.K.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of HEALIOS K.K. is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, HEALIOS K.K.’s stock price was EUR 0.95. HEALIOS K.K.’s stock price has changed by -8.25% over the past week, -12.50% over the past month and -14.86% over the last year.
No recent analyst target price found for HEALIOS K.K.
No recent average analyst rating found for HEALIOS K.K.
Company Overview HEALIOS K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan. Read Less
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for...Read More
Frequently Asked Questions About HEALIOS K.K. (6VX:F) Stock
Stock Target Advisor's fundamental analysis for HEALIOS K.K.'s stock is Very Bearish.
Unfortunately we do not have enough data on 6VX:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 6VX:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 6VX:F's stock to indicate if its overvalued.
The last closing price of 6VX:F's stock was EUR 0.95.
The most recent market capitalization for 6VX:F is EUR 0.11B.
Unfortunately we do not have enough analyst data on 6VX:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains HEALIOS K.K.'s stock.
As per our most recent records HEALIOS K.K. has 64 Employees.
HEALIOS K.K.'s registered address is Hibiya Mitsui Tower, Tokyo, Japan, 100-0006.
You can get more information about it from HEALIOS K.K.'s website at https://www.healios.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About HEALIOS K.K. (6VX:F) Stock
Stock Target Advisor's fundamental analysis for HEALIOS K.K.'s stock is Very Bearish.
Unfortunately we do not have enough data on 6VX:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 6VX:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 6VX:F's stock to indicate if its overvalued.
The last closing price of 6VX:F's stock was EUR 0.95.
The most recent market capitalization for 6VX:F is EUR 0.11B.
Unfortunately we do not have enough analyst data on 6VX:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains HEALIOS K.K.'s stock.
As per our most recent records HEALIOS K.K. has 64 Employees.
HEALIOS K.K.'s registered address is Hibiya Mitsui Tower, Tokyo, Japan, 100-0006.
You can get more information about it from HEALIOS K.K.'s website at https://www.healios.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 6VX:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
